Anavia, an Edge Group entity, exhibited a scale model of the naval version of its HT-100 unmanned aerial vehicle (UAV) at the ...

"Breast carcer is one of the most common cancers worldwide. Despite many great advancements in its diagnosis and treatment, so much still remains to be learned, particularly about the rare forms ...

"Receiving FDA approval for expanded use of LP-310 represents a key milestone in our mission to address the significant unmet need in oral lichen planus treatment." He expressed the company's ...

a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion ...

The automated MRD analysis patent focuses on systems interfacing with laboratory equipment, while the patient journey patent is relevant to MRD methods applied throughout a patient's treatment and ...

In a report released yesterday, Brett Linzey from Mizuho Securities maintained a Hold rating on IDEX (IEX – Research Report). The company’s shares closed yesterday at $218.65. Leverage the ...

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the quarter and year ended December 31, 2024. "IDEX teams drove a strong finish to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...